Physician profile
Andrew Robert Olson
NPI 1831466648
$2,580.04
in general payments reported to CMS, 2019-2025
17 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $236 · 2021: $468 · 2022: $177 · 2023: $343 · 2024: $564 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.14 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $701.64 | 2019-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $349.77 | 2023-2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $304.78 | 2019-2025 | Lifevest |
| United Therapeutics Corporation | $266.98 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $234.79 | 2019-2024 | Leqvio |
| Merck Sharp & Dohme LLC | $177.73 | 2022-2025 | Verquvo |
| Amgen INC. | $140.93 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $105.06 | 2024 | Assure Wcd |
| Stryker Corporation | $103.27 | 2025 | Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $58.04 | 2019-2025 | Eliquis |
| Boston Scientific Corporation | $23.16 | 2024 | Watchman Access System |
| Abbott Laboratories | $21.22 | 2025 | Cardiomems |
| Amarin Pharma, INC. | $21.00 | 2020 | |
| Sanofi-Aventis U.S. LLC | $19.46 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $18.99 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $18.27 | 2025 | Brilinta |
| Abiomed | $14.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.